Clinuvel Pharmaceuticals
CUV.AX
#8618
Rank
NZ$0.47 B
Marketcap
NZ$9.47
Share price
1.75%
Change (1 day)
-25.43%
Change (1 year)

Earnings for Clinuvel Pharmaceuticals (CUV.AX)

Earnings in 2026: NZ$58.9 Million

According to Clinuvel Pharmaceuticals's latest financial reports the company's current earnings are NZ$64.99 Million. In 2026 the company made an earning of NZ$58.9 Million a decrease over its 2025 earnings that were of NZ$60.63 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Clinuvel Pharmaceuticals from 2000 to 2026

Annual earnings

Year Earnings Change
2026NZ$58.9 M-2.84%
2025NZ$60.63 M0.26%
2024NZ$60.47 M11.35%
2023NZ$54.3 M28.31%
2022NZ$42.32 M22.8%
2021NZ$34.47 M112.63%
2020NZ$16.21 M-28.73%
2019NZ$22.74 M32.79%
2018NZ$17.13 M75.41%
2017NZ$9.76 M-332.52%
2016-NZ$4.21 Million-70.68%
2015-NZ$14.33 Million53.78%
2014-NZ$9.32 Million-16.1%
2013-NZ$11.11 Million-37.92%
2012-NZ$17.89 Million-18.19%
2011-NZ$21.87 Million25.31%
2010-NZ$17.45 Million-21.53%
2009-NZ$22.24 Million-11.27%
2008-NZ$25.07 Million80.4%
2007-NZ$13.9 Million-2.46%
2006-NZ$14.25 Million-5.35%
2005-NZ$15.05 Million60.55%
2004-NZ$9.38 Million97.37%
2003-NZ$4.75 Million50.62%
2002-NZ$3.16 Million121.22%
2001-NZ$1.43 Million254.48%
2000-NZ$0.41 Million